TerminatedNot Applicable

Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD

Stopped: Study was stopped secondary to principal investigator needing to analyze data and present prior to graduating. Target enrollment not able to be reached prior to this.

United States4 participantsStarted 2021-09-07

Plain-language summary

This is a project that will determine whether the use of daily bright light therapy has an effect on depressive symptoms experienced by adult inpatients with CF and COPD. The purpose of this project is to apply a daily 30-minute BLT intervention to hospitalized adult CF and COPD patients in order to decrease symptoms of depression as measured by depression inventory scoring.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with cystic fibrosis or chronic obstructive pulmonary disease (COPD) * Adult age 18 or older * Admitted to the pulmonary step-down and transplant unit * Score greater than zero on pre-intervention Beck's Depression Inventory-II (BDI-II) Exclusion Criteria: * Pre-existing ophthalmological conditions or photosensitivity * Migraines * Receiving high dose steroids for transplant rejection (due to mood altering qualities), * Antibiotics that increase light sensitivity * Diagnosed with bipolar disorder (light therapy may trigger mania) * Admissions anticipated to span less than 48 hours * Children are being excluded due to the fact that only adult CF and COPD subjects are admitted to University of Pittsburgh Medical Center (UPMC) Presbyterian hospital

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Pre- and Post-intervention Beck's Depression Inventory II Scores (BDI-II)

Timeframe: First at time of admission, second at end of 7 day goal or upon discharge.

Trial details

NCT IDNCT04921332

SponsorErica Osborn

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-22

Results submitted2023-01-25

View on ClinicalTrials.gov More Cystic Fibrosis trials